Kai Dallmeier

Papers

Total Citations

H-Index

About

Kai Dallmeier is a leading virologist whose research focuses on the development of innovative antiviral strategies and high-throughput screening platforms for emerging flaviviruses, particularly dengue virus. His major contributions include pioneering a dengue type 2 reporter virus assay that expresses the fluorescent protein mCherry, enabling rapid, high-content imaging-based drug discovery. This work, published in 2020 and already cited 21 times, provides a critical tool for identifying potent anti-dengue compounds, addressing the urgent need for prophylaxis and treatment against a pathogen threatening nearly half the global population. Dallmeier’s approach bridges molecular virology and translational medicine, offering a scalable platform for evaluating antiviral efficacy. His achievements highlight a commitment to combating mosquito-borne diseases through innovative assay design, positioning him as a key figure in the fight against flavivirus outbreaks.